Xencor | XNCR - Operating Profit

Stock Price
10.82
Daily Change
-0.71 -6.16%
Monthly
-23.04%
Yearly
-37.28%
Q1 Forecast
11.72

Xencor reported $-47.52M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Alnylam Pharmaceuticals USD -29.96M 13.76M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Arrowhead Research USD 44.11M 209.66M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
J&J USD 5.59B 1.81B Dec/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Merck USD 6.24B 318M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Xencor USD -47.52M 14.35M Sep/2025